DK393188A - Farmaceutisk praeparat til intranasal administrering - Google Patents

Farmaceutisk praeparat til intranasal administrering

Info

Publication number
DK393188A
DK393188A DK393188A DK393188A DK393188A DK 393188 A DK393188 A DK 393188A DK 393188 A DK393188 A DK 393188A DK 393188 A DK393188 A DK 393188A DK 393188 A DK393188 A DK 393188A
Authority
DK
Denmark
Prior art keywords
intranasal administration
pharmaceutical preparation
hypophyseal
ghrh
diagnosis
Prior art date
Application number
DK393188A
Other languages
English (en)
Other versions
DK393188D0 (da
Inventor
Franklin M Boghen
Franco Camanni
Soldato Piero Del
Ezio Ghigo
Eugenio E Muller
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of DK393188D0 publication Critical patent/DK393188D0/da
Publication of DK393188A publication Critical patent/DK393188A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK393188A 1987-07-30 1988-07-14 Farmaceutisk praeparat til intranasal administrering DK393188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21513/87A IT1222395B (it) 1987-07-30 1987-07-30 Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare

Publications (2)

Publication Number Publication Date
DK393188D0 DK393188D0 (da) 1988-07-14
DK393188A true DK393188A (da) 1989-01-31

Family

ID=11182925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK393188A DK393188A (da) 1987-07-30 1988-07-14 Farmaceutisk praeparat til intranasal administrering

Country Status (12)

Country Link
US (1) US5010056A (da)
EP (1) EP0301392B1 (da)
JP (1) JPS6450823A (da)
KR (1) KR890001584A (da)
AT (1) ATE76753T1 (da)
AU (1) AU618547B2 (da)
DK (1) DK393188A (da)
IT (1) IT1222395B (da)
NO (1) NO883200L (da)
NZ (1) NZ225546A (da)
PH (1) PH26712A (da)
ZA (1) ZA885417B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0383931A (ja) * 1989-08-29 1991-04-09 Sumitomo Pharmaceut Co Ltd 低刺激性ｇｒｆ経鼻投与製剤
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
US5502067A (en) * 1994-02-04 1996-03-26 Morgan; Julia A. Treating apneahypopnea/snoring in humans
US5500205A (en) * 1994-02-23 1996-03-19 Enviro Pac International, L.I.C. Lachrymator aerosol formulations
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
AUPN801296A0 (en) 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
CN1127333C (zh) * 1997-02-24 2003-11-12 S.L.A.药业股份公司 含有胆碱能药物或钙通道阻滞剂的局部用医药组合物
ATE289825T1 (de) * 1999-04-21 2005-03-15 1355540 Ontario Inc Methacoline oder histamine formulierungen zur feststellung von asthma
JP2005505491A (ja) * 1999-06-02 2005-02-24 ヘキサル・アクチェンゲゼルシャフト 水溶性活性物質の鼻腔内投与用医薬組成物
WO2001041732A1 (en) * 1999-12-06 2001-06-14 Gore Stanley L Compositions and methods for intranasal delivery of active agents to the brain
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
US8299079B2 (en) * 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
EP3027637B1 (en) * 2013-08-01 2019-10-09 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services The glycine conjugate of beta-muricholic acid as an inhibitor of the farnesoid x receptor for the treatment of obesity, insulin resistance or non-alcoholic fatty liver disease
EP4203958A4 (en) * 2020-08-26 2024-10-09 Oticara, Inc. COMPOSITIONS, DEVICES AND METHODS FOR TREATING NOSE, EAR AND OTHER TISSUE INFECTIONS AND/OR INFECTIONS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ206518A (en) * 1982-12-10 1989-06-28 Syntex Inc Nasal composition comprising nona- or deca-peptide lhrh analogue and bile acid surfactant
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IT1169873B (it) * 1983-10-21 1987-06-03 Prodotti Formenti Srl Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
US4818531A (en) * 1985-02-06 1989-04-04 Eli Lilly And Company Growth hormone and thyroid hormone
JPS62126135A (ja) * 1985-11-25 1987-06-08 Sumitomo Pharmaceut Co Ltd 経鼻投与用ｇｒｆ製剤
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof

Also Published As

Publication number Publication date
ATE76753T1 (de) 1992-06-15
EP0301392A1 (en) 1989-02-01
DK393188D0 (da) 1988-07-14
AU2005188A (en) 1989-02-02
NZ225546A (en) 1990-12-21
EP0301392B1 (en) 1992-06-03
NO883200D0 (no) 1988-07-19
KR890001584A (ko) 1989-03-27
AU618547B2 (en) 1992-01-02
NO883200L (no) 1989-01-31
IT8721513A0 (it) 1987-07-30
IT1222395B (it) 1990-09-05
ZA885417B (en) 1989-06-28
PH26712A (en) 1992-09-15
JPS6450823A (en) 1989-02-27
US5010056A (en) 1991-04-23

Similar Documents

Publication Publication Date Title
DK393188D0 (da) Farmaceutisk praeparat til intranasal administrering
DK203787A (da) Praeparat til nasal administrering
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO902710D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DK134990D0 (da) Praeparat til tandbehandling samt fremgangsmaade til fremstilling deraf
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
NZ231320A (en) Aqueous oral preparations of diclofenac
DK325289D0 (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DE3788338D1 (de) Vorbehandlungswirkstoff zur perkutanen verabreichung.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
AU3934689A (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
AU1621788A (en) Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
FI874450A7 (fi) Farmaseuttiset valmisteet alkuperältään toiminnallisten ja elimelliste n aivohäiriöiden hoitamiseen.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO167144C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
DK0486586T3 (da) Kynurensyrederivater, fremstilling deraf og farmaceutiske præparater, der indeholder dem
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
NO881554L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-((1,1-difenyl)-1-alkenyl)piperazin-derivater og farmasoeytisk aksepterbare salter av disse derivater.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment